These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 31307549)

  • 1. Visual and treatment outcomes of tubercular uveitis: a prospective case series from a referral hospital in Pakistan.
    Ghauri MI; Iqbal N; Riaz SU; Irfan M; Kumar A; Mukarram MS
    BMC Res Notes; 2019 Jul; 12(1):404. PubMed ID: 31307549
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnosis and treatment of tuberculous uveitis in a low endemic setting.
    Vos AG; Wassenberg MW; de Hoog J; Oosterheert JJ
    Int J Infect Dis; 2013 Nov; 17(11):e993-9. PubMed ID: 23706496
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Treatment of presumed tuberculous uveitis affecting the posterior segment: diagnostic confirmation and long term outcomes].
    Cordero-Coma M; Garzo I; Salazar R; Franco M; Calleja S; Ruiz de Morales JM
    Arch Soc Esp Oftalmol; 2013 Sep; 88(9):339-44. PubMed ID: 23988040
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical Features and Outcomes of Patients With Tubercular Uveitis Treated With Antitubercular Therapy in the Collaborative Ocular Tuberculosis Study (COTS)-1.
    Agrawal R; Gunasekeran DV; Grant R; Agarwal A; Kon OM; Nguyen QD; Pavesio C; Gupta V;
    JAMA Ophthalmol; 2017 Dec; 135(12):1318-1327. PubMed ID: 29075752
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Collaborative Ocular Tuberculosis Study Consensus Guidelines on the Management of Tubercular Uveitis-Report 2: Guidelines for Initiating Antitubercular Therapy in Anterior Uveitis, Intermediate Uveitis, Panuveitis, and Retinal Vasculitis.
    Agrawal R; Testi I; Bodaghi B; Barisani-Asenbauer T; McCluskey P; Agarwal A; Kempen JH; Gupta A; Smith JR; de Smet MD; Yuen YS; Mahajan S; Kon OM; Nguyen QD; Pavesio C; Gupta V;
    Ophthalmology; 2021 Feb; 128(2):277-287. PubMed ID: 32603726
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early treatment of tuberculous uveitis improves visual outcome: a 10-year cohort study.
    Anibarro L; Cortés E; Chouza A; Parafita-Fernández A; García JC; Pena A; Fernández-Cid C; González-Fernández Á
    Infection; 2018 Aug; 46(4):549-554. PubMed ID: 29869018
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-tubercular therapy in the treatment of tubercular uveitis: A systematic review and meta-analysis.
    Betzler BK; Putera I; Testi I; La Distia Nora R; Kempen J; Kon OM; Pavesio C; Gupta V; Agrawal R
    Surv Ophthalmol; 2023; 68(2):241-256. PubMed ID: 36272559
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The efficacy of latent tuberculosis treatment for immunocompetent uveitis patients with a positive T-SPOT.TB test: 6-year experience in a tuberculosis endemic region.
    Chung CY; Li KKW
    Int Ophthalmol; 2018 Dec; 38(6):2273-2282. PubMed ID: 28948453
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of Antituberculous Therapy on Uveitis Associated With Latent Tuberculosis.
    Tomkins-Netzer O; Leong BCS; Zhang X; Lightman S; McCluskey PJ;
    Am J Ophthalmol; 2018 Jun; 190():164-170. PubMed ID: 29604284
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Global prevalence and clinical outcomes of tubercular uveitis: a systematic review and meta-analysis.
    Alli HD; Ally N; Mayet I; Dangor Z; Madhi SA
    Surv Ophthalmol; 2022; 67(3):770-792. PubMed ID: 34626620
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Simultaneous mutually exclusive active tubercular posterior uveitis.
    Ramanjulu R; Dubey D; Shanmugam MP
    Indian J Ophthalmol; 2020 Sep; 68(9):2049-2050. PubMed ID: 32823477
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of anti-tubercular therapy in uveitis with latent/manifest tuberculosis.
    Bansal R; Gupta A; Gupta V; Dogra MR; Bambery P; Arora SK
    Am J Ophthalmol; 2008 Nov; 146(5):772-9. PubMed ID: 18708180
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of anti-tubercular therapy in patients with presumed ocular tuberculosis.
    Agrawal R; Gupta B; Gonzalez-Lopez JJ; Rahman F; Phatak S; Triantafyllopoulou I; Addison PK; Westcott M; Pavesio CE
    Ocul Immunol Inflamm; 2015 Feb; 23(1):40-6. PubMed ID: 25615809
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Duration of anti-tubercular therapy in uveitis associated with latent tuberculosis: a case-control study.
    Ang M; Hedayatfar A; Wong W; Chee SP
    Br J Ophthalmol; 2012 Mar; 96(3):332-6. PubMed ID: 21719564
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment outcome in patients with presumed tubercular uveitis at a tertiary referral eye care centre in Singapore.
    Ang L; Kee A; Yeo TH; Dinesh VG; Ho SL; Teoh SC; Agrawal R
    Int Ophthalmol; 2018 Feb; 38(1):11-18. PubMed ID: 28035499
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tuberculous uveitis in China.
    Mao Y; Peng XY; You QS; Wang H; Zhao M; Jonas JB
    Acta Ophthalmol; 2014 Aug; 92(5):e393-7. PubMed ID: 24479692
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Progressive ocular inflammation following anti-tubercular therapy for presumed ocular tuberculosis in a high-endemic setting.
    Basu S; Nayak S; Padhi TR; Das T
    Eye (Lond); 2013 May; 27(5):657-62. PubMed ID: 23449506
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical Profile and Treatment Response of Patients with Ocular Inflammation due to Presumed Ocular Tuberculosis: A Retrospective Study.
    Elangovan S; Govindarajan S; Mayilvakanam L; Gunasekaran N
    Turk J Ophthalmol; 2019 Sep; 49(4):188-193. PubMed ID: 31486605
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mycobacterial ocular inflammation: delay in diagnosis and other factors impacting morbidity.
    Patel SS; Saraiya NV; Tessler HH; Goldstein DA
    JAMA Ophthalmol; 2013 Jun; 131(6):752-8. PubMed ID: 23579549
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognosis of Ocular Tuberculosis Following Long-Term Antitubercular Therapy.
    Jiang T; Zhang X; Zhou M; Jiang R; Chang Q
    J Ocul Pharmacol Ther; 2021 May; 37(4):241-247. PubMed ID: 33524301
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.